Indisulam

Indisulam is a chloroindolyl sulfonamide cell cycle inhibitor that exhibits antitumor activity in vitro and in an animal model.^[1][2][3] This compound affects cell cycle progression in human tumor cells and is being studied for the treatment of cancers such as melanomas and blood-borne cancers such as leukemia.^[4]

Indisulam

Names
Preferred IUPAC name N1-(3-Chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
Other names E7070
Identifiers
CAS Number	165668-41-7
3D model (JSmol)	Interactive image
ChEBI	CHEBI:145431
ChEMBL	ChEMBL77517
ChemSpider	187608
DrugBank	DB06370
KEGG	D04522
PubChem CID	216468
UNII	WJ98J3NM90
CompTox Dashboard (EPA)	DTXSID50168008
InChI InChI=1S/C14H12ClN3O4S2/c15-12-8-17-14-11(12)2-1-3-13(14)18-24(21,22)10-6-4-9(5-7-10)23(16,19)20/h1-8,17-18H,(H2,16,19,20) Key: SETFNECMODOHTO-UHFFFAOYSA-N
SMILES C1=CC2=C(C(=C1)NS(=O)(=O)C3=CC=C(C=C3)S(=O)(=O)N)NC=C2Cl
Properties
Chemical formula	C14H12ClN3O4S2
Molar mass	385.84 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references